If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 21 - 30 of 275
Phase I/II Study of Tandem, Bispecific Anti-CD19 Anti-CD20 CAR-T Cells for Patients with Relapsed and/or Refractory B Cell Malignancies
Study of tandem, bispecific anti-CD19 anti-CD20 CAR-T cells for Patients with Relapsed and/or Refractory B Cell Malignancies
Protocol No
IIT-SHAH-IL7-IL15-CD20-19
Categories
A Phase 1, First-in-human (FIH), Dose-finding and Expansion Study to Evaluate the Safety and Tolerability of XmAb808 in Combination with Pembrolizumab in Selected Advanced Solid Tumors
A Phase 1 Study of XmAb808 in Select Advanced Solid Tumors
Protocol No
XENCOR-XMAB808-01
TES To Remediate Phonological Impairments After Stroke
TES for Language Impairment
Protocol No
NEURO-IIT-SHAH-TES
Categories
Examination of Motor Unit Alterations in Acute and Subacute Stroke
Motor Unit Alterations in Acute and Subacute Stroke
Protocol No
NEURO-IIT-LI-MOTOR-UNIT-ALT
Categories
A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia
HD-tDCS for Phonological Impairment in Aphasia
Protocol No
NEURO-IIT-PILLAY-ALF-TDCS
A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Patients with Mature B-Cell Malignancies
A Phase 1 Study if SGR-1505 in Patients with B-Cell Malignancies
Protocol No
SCHRODINGER-SGR-1505-101
Categories
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Protocol No
PULM-VERACYTE-ENVISIA-ILD
Categories
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Role of Autophagy in Type 2 Diabetes Microvascular Dysfunction
Protocol No
CVC-IIT-BEYERS-AMF-T2DM
Categories
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP
II TR): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial To
Evaluate The Safety And Effectiveness Of Transcatheter Tricuspid Valve Repair With
The Ed
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP II TR)
Protocol No
CVC-EDWARDS-PASCAL-CLASP
Categories
A Randomized Phase II Study Comparing Inotuzumab Plus Chemotherapy Versus Standard Chemotherapy in Older Adults with Philadelphia-Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
This study is being done to answer the following question: Can we improve the chance of your leukemia going away (remission) and lower the chance of your leukemia coming back (relapsing) by adding an investigational drug called inotuzumab ozogamicin (hereafter, inotuzumab) to lower doses of the usual chemotherapy for acute lymphoblastic leukemia?
We are doing this study because we want to find out if this approach is better or worse than the
usual approach for your acute lymphoblastic leukemia. The usual approach is defined as care
most people get for acute lymphoblastic leukemia.
We are doing this study because we want to find out if this approach is better or worse than the
usual approach for your acute lymphoblastic leukemia. The usual approach is defined as care
most people get for acute lymphoblastic leukemia.
Protocol No
ALLIANCE-A042001
Categories